HYPERION DEFI, INC. Share Price
HYPERION DEFI, INC. (HYPD) had Share Price of $3.56 per share as of 2025-12-31, per its DEF 14A filed 2026-05-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-05-05
- 2025-12-31: Share Price $3.56.
- 2024-12-31: Share Price $0.15.
- 2024-09-30: Share Price $0.68.
- 2023-12-31: Share Price $2.08.
| Period end | Share Price |
|---|---|
| 2025-12-31 | $3.56 DEF 14A · filed 2026-05-05 |
| 2024-12-31 | $0.15 DEF 14A · filed 2026-05-05 |
| 2024-09-30 | $0.68 10-Q · filed 2024-11-12 |
| 2023-12-31 | $2.08 DEF 14A · filed 2026-05-05 |
| 2023-09-30 | $1.97 10-Q · filed 2024-11-12 |
| 2022-12-31 | $1.63 DEF 14A · filed 2026-05-05 |
| 2017-03-31 | $3.23 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |